Anhui Huaren Health Pharmaceutical Past Earnings Performance
Past criteria checks 1/6
Anhui Huaren Health Pharmaceutical has been growing earnings at an average annual rate of 20.1%, while the Consumer Retailing industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 18.2% per year. Anhui Huaren Health Pharmaceutical's return on equity is 6.9%, and it has net margins of 3.3%.
Key information
20.1%
Earnings growth rate
17.0%
EPS growth rate
Consumer Retailing Industry Growth | 12.8% |
Revenue growth rate | 18.2% |
Return on equity | 6.9% |
Net Margin | 3.3% |
Next Earnings Update | 29 Aug 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Anhui Huaren Health Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 4,056 | 133 | 1,016 | 28 |
31 Dec 23 | 3,797 | 115 | 964 | 24 |
30 Sep 23 | 3,703 | 180 | 935 | 11 |
30 Jun 23 | 3,584 | 177 | 891 | 8 |
31 Mar 23 | 3,431 | 175 | 851 | 6 |
01 Jan 23 | 3,262 | 161 | 808 | 4 |
01 Jan 22 | 2,339 | 70 | 692 | 0 |
31 Dec 20 | 1,931 | 89 | 564 | 0 |
31 Dec 19 | 1,522 | 52 | 483 | 0 |
31 Dec 18 | 1,105 | 20 | 377 | 0 |
Quality Earnings: 301408 has a high level of non-cash earnings.
Growing Profit Margin: 301408's current net profit margins (3.3%) are lower than last year (5.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301408's earnings have grown significantly by 20.1% per year over the past 5 years.
Accelerating Growth: 301408's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 301408 had negative earnings growth (-23.9%) over the past year, making it difficult to compare to the Consumer Retailing industry average (-6.9%).
Return on Equity
High ROE: 301408's Return on Equity (6.9%) is considered low.